New Expression – 365 Under Eye Fix

A plethora of the latest technologically advanced peptides are utilised due to their specific benefits on the under-eye area, targeting and reducing crow’s feet wrinkles in density and depth with myo-relaxing action, offering rapid and reversible muscle and nerve relaxing effects, for safe application in the under eye and crow’s feet area, where the use of injectable myo-relaxors is restricted. Importantly it fades under-eye dark circles, decongesting and reducing puffiness, forming a continuous film with tensor effect.

Customers who bought this also bought


There is a gradual, continual release of actives into the skin, with an immediate lifting, eye contour smoothing effect, offering 24-hour residual relaxing power. Has a preventative as well as revitalizing action, helping delay the formation and deepening of expression wrinkles. Use morning and night as this product has a cumulative effect and skin will begin to look noticeably smoother and more youthful.

Directions For Use:

AM & PM: Cleanse with RégimA and apply Revolution-EYZ serum to the upper eyelids. Then apply a small amount of Under Eye Fix to the whole under-eye area, crow’s feet and between the eyebrows on frown lines. (Do not apply to upper eyelids) Because there is a cumulative effect if applied twice daily one receives the extra benefit. The combination of RégimA Zone Revolution-EYZ and New Expression-365 Under Eye Fix is highly recommended.

Additional information

Product Size:


Best for Skin Concern:

Mature and Sun Damaged Skin

Best for Skin Type:

Dry, Normal, Oily


Eye Area

Key Ingredients:

Chicory Root Oligosaccharides, Hesperidin Methyl Chalcone, Hydroxysuccinimide, Palmitoyl Oligopeptide


There are no reviews yet.

Be the first to review “New Expression – 365 Under Eye Fix”

Your email address will not be published. Required fields are marked *

Questions and answers of the customers

There are no questions yet. Be the first to ask a question about this product.

Send me a notification for each new answer.